Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Revises Zelnorm Labeling With Diarrhea, Ischemic Colitis Risk Info

Related Content

Novartis Zelnorm Approval: FDA Accepts Overseas History, Active Surveillance

Jul 29 2002

Glaxo Lotronex Withdrawal Follows Failed Risk Management Negotiations

Dec 04 2000

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window